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Massive localized lymphedema (MLL) is a rare condition observed in the morbidly obese popu-lations. The epidemiology of MLL is currently 
unknown, but due to increasing prevalence of obesity 
worldwide,1,2 its incidence is expected to rise. MLL is asso-
ciated with disturbance of efferent lymphatic flow possi-
bly due to extensive adipose tissue.3 Other possible causes 
include previous surgery, trauma, and hypothyroidism.4 
However, the pathogenesis of MLL remains to be fully 
elucidated. Therefore, diagnosing MLL can be clinically, 
pathologically, and radiologically challenging as these soft 
tissue lesions can mimic malignancy. Multiple published 
reports describe oncological resection of MLL as patients 
usually present with large masses that radiologically and 
histologically mimic liposarcoma or lymphosarcoma,5–7 
hence MLL has been termed “pseudosarcoma.”8 Also of 
concern are reports identifying MLL as a risk factor for 
the development of angiosarcoma.9–12
Depending on clinical history, anatomical site, exami-
nation, and investigations, MLL can be managed con-
servatively or surgically. Conservative measures include 
antibiotics, for associated cellulitis and complete decon-
gestive therapy.13,14 Surgery is advocated when there is 
functional deficit, including immobility, recurrent infec-
tions, and suspicion of malignancy.15
MLL has been reported to affect various anatomi-
cal sites including thigh, popliteal fossa, scrotum, 
mons pubis, and abdomen.4,13 Relevant to this report, 
abdominal MLL is associated with significant functional 
disabilities of mobilization, back pain, skin intertrigo, 
suprapubic edema, and poor local hygiene. Abdominal 
dermolipectomy is the recommended surgical proce-
dure, although it is considered a cosmetic procedure 
by most institutions.16 In the United States, this opera-
tion may be covered by medical insurance,17 but in 
the United Kingdom it is done in the private sector or 
with funding approval on the National Health Service 
(NHS).
With Individual Funding Request approval,18 our 
patient was treated on the NHS. The process took about 
a year to complete, further increasing her morbidity. The 
perioperative planning is discussed with a satisfactory out-
come and further plan for gastric banding. To the best 
of our knowledge, this is the largest abdominal debulking 
procedure reported in the United Kingdom.
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Summary: Massive localized lymphedema of the abdomen is a rare condition 
resulting from a neglected lower abdominal pannus associated with significant 
disability and morbidity. Compared to other surgical procedures, postbariat-
ric surgery is usually considered a financial drain. In the United Kingdom, this 
requires National Health Service approval and delays may lead to sequelae that 
adversely impact on patients’ quality of life with increased morbidity. We present 
a wheelchair-bound patient whose body mass index increased from 53 to 82, while 
awaiting funding approval increasing her anesthetic and surgical risks. A multi-
disciplinary approach is mandatory for preoperative, intraoperative, and postop-
erative care for these patients including anesthetic input and high dependency 
unit care. Managing this patient was a significant anesthetic and surgical challenge 
with 47-kg resected tissue. The planning and perioperative measures to minimize 
morbidity are discussed. (Plast Reconstr Surg Glob Open 2020;8:e2601; doi: 10.1097/
GOX.0000000000002601; Published online 17 January 2020.)
Massive Localized Abdominal Lymphedema 
Treatment Challenges
Case RepoRt
PRS Global Open • 2020
2
CASE REPORT
A 51-year-old white woman with the history of hyper-
tension, vitamin D deficiency, and severe osteoarthritis 
presented with morbid obesity and concerns about an 
overhanging pannus which had progressively increased 
over 8 years with significant deterioration of her personal 
care, hygiene, and overall quality of life (QOL).19 She was 
wheelchair bound and barely managed to mobilize from 
her bed with crutches.
She was referred to Plastics after a failed laparoscopic 
gastric sleeve procedure due the excessive thickness 
(approximately 6 cm) of the anterior abdominal wall. 
She was morbidly obese with a large pannus extending 
down to her lower legs with peau de’orange appearance 
and ulceration [body mass index (BMI): 53; height: 1.57 
m; weight: 133 kg]. A lower abdominal apronectomy was 
planned, without umbilical preservation on the NHS. The 
funding approval took over a year during which time the 
patient gained 69 kg (weight: 202 kg; BMI: 82) with dete-
rioration in mobility, personal care, and “morale” (Fig. 1).
The apron now reached her ankles with worsening 
lymphedema and mobilization. In addition to surgery, she 
had significant anesthetic risks such as deep vein throm-
bosis, myocardial infarction, and pulmonary embolism. 
A computed tomography (CT) scan confirmed a 14  cm 
× 7  cm midline rectus defect with no bowel herniation. 
She required a bariatric bed, specialized operating table 
with extensions, and postoperative high dependence unit 
care. Preoperative planning included deep vein thrombo-
sis prophylaxis with daily 9,000-U tinzaparin, thromboem-
bolic deterrent stockings, and Flowtron pumps.
The surgery involved 2 teams to minimize anesthesia 
duration and surgical risks. The apron en bloc excision was 
started superiorly above the umbilicus till the suprapubic 
area was reached over the rectus sheath. This was done to 
reduce the time, and the apron was then lifted supero-later-
ally, so minimizing the burden on the patient’s vitals and res-
piration. The major blood vessels identified in the CT scan, 
including large superficial inferior epigastric veins (2.7 cm 
diameter), were preemptively ligated and rectus sheath 
defect plicated using a double running 2/0 polydioxanone 
suture. The umbilicus sacrificed to complete the lower inci-
sion. The excision was completed removing a 47-kg abdom-
inal pannus. The wound was closed in layers with quilting, 
fibrin sealant, and vacuum assisted closure drains without 
undermining to minimize wound-healing complications 
(see figure, Supplemental Digital Content 1, which displays 
preoperative transverse CT scans of patient demonstrating 
the size of superficial inferior epigastric vessels, http://
links.lww.com/PRSGO/B278) (see figure, Supplemental 
Digital Content 2, which displays intraoperative clinical 
photography of excised surgical pannus, http://links.lww.
com/PRSGO/B279) (see figure, Supplemental Digital 
Content 3, which displays intraoperative clinical photogra-
phy of surgical defect following excision of pannus, http://
links.lww.com/PRSGO/B280).
The abdominal wound was closed in multiple lay-
ers with quilting polydioxanone sutures and fibrin glue 
(ARTISS, Baxter, UK), to prevent collection. Two vacuum 
assisted closure drains on each side were used on 80 mm 
Hg intermittent pressure to further prevent fluid collec-
tion (RENASYS; Smith & Nephew, London, UK). She 
mobilized early with physiotherapy and was discharged 
on the 17th postoperative day. She had 2 areas of minor 
wound breakdown which healed with dressings. Three 
months postoperatively, she weighed 149 kg (BMI: 60) 
and was able to mobilize with minimal support (Fig. 2).
DISCUSSION
Morbid obesity is a complex multifactorial problem 
that adversely affects an individual’s health and QOL.20,21 
It also impacts morbidity and increases the risk for malig-
nancy, cardiovascular disease, diabetes, osteoarthritis,22 and 
higher all-cause mortality.23 This is concerning, as obesity 
prevalence is increasing worldwide,1,2 with an economic 
burden and increasing annual total health-care costs by 
Fig. 1. preoperative clinical photographs of the patient with walking aids. a, Front view. B, Right lateral 
view.
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36%,24 matching that of smoking and all armed conflict.25 
In the United Kingdom, most bariatric procedures are per-
ceived as “cosmetic” and therefore not routinely funded on 
the NHS, without a specific Individual Funding Request 
approval. This took more than a year for our patient result-
ing her gaining 68  kg, significantly increasing anesthetic 
and surgical risks,26 including difficult intubation, airway 
management, cardiorespiratory compromise, reduced lung 
compliance, increased ventilation-perfusion (V/Q) scan 
mismatch, and systemic and pulmonary hypertension.26,27
Intravenous access is difficult for drug administra-
tion, and adipose tissue influences the pharmacoki-
netics of many drugs and general anesthetic agents.27 
Intraoperatively, there is an increased risk of deep vein 
thrombosis, myocardial infarction, pulmonary embolism, 
and stroke.26 Meticulous preoperative planning and effi-
cient surgical execution are imperative to minimize com-
plications and morbidity. A 2-team approach also reduces 
the operating/anesthetic time.
Standard apronectomy involves an incision in the 
patient’s natural suprapubic crease that extended laterally 
toward and beyond the anterior superior iliac spine. The 
incision is then deepened down to the musculoaponeu-
rotic plane, which is followed superiorly. The apron is then 
excised and umbillectomy performed if needed. Sachs and 
Murray28 have published an overview of panniculectomies in 
detail. This classical approach may not be feasible in extreme 
cases such as abdominal MLL, where apronectomy/pannic-
ulectomy carries technical challenges.29–41 Various measures 
have been described to lift the “apron,” including overhead 
cranes, Steinmann pins with pulleys, and hydraulic lifts.34,37,42 
In our patient, these were considered unsafe by medical 
engineering. An extension to the operating table was used 
to abduct the legs to rest the apron.
Weathers et al reported a 94-kg apron resection.37 
In the United Kingdom, weights of 25.4 and 35 kg were 
reported.35,41 This patient with 47-kg resection would pos-
sibly be the largest apron resection reported till date in 
the United Kingdom.
Obesity is associated with multiple postoperative com-
plications including wound infection and dehiscence.43 
Koulaxouzidis et al reported 37% incidence of wound 
breakdown following apronectomy.33 Manahan and 
Shermak also reported 20% wound-related complications 
following massive panniculectomy.40 Our patient had a 
minor wound breakdown which healed with dressings.
CONCLUSIONS
MLL is a challenging surgical problem due to a 
neglected abdominal apron that merits early recognition 
and intervention. Surgical management needs careful 
multidisciplinary perioperative planning. Delay increases 
risks further worsening mobility and morale. Adjuncts of 
quilting sutures, use of fibrin glue, and vacuum assisted 
closure dressings also reduce complications. The improve-
ment in the patients’ QOL more than compensates for 
the initial surgical cost including benefits by reduction in 
ongoing nursing and social care expenses.44
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